Dr. Penka Petrova

Chief Development Officer

Dr. Petrova has 20 years of experience in the biotechnology industry and has advanced several Trillium programs across multiple drug development areas, spanning discovery research, preclinical target validation, IND-enabling studies, and clinical development. She joined Trillium in 2003 from Prescient Neuropharma, where she was instrumental in the discovery and characterization of novel protective neurotrophic factors in neurodegenerative diseases. Dr. Petrova received her Ph.D. in Microbiology from Saarland University in Saarbruecken, Germany, where she also conducted her postdoctoral studies in oncology and tumor immunology under Dr. Michael Pfreundschuh at Saarland University Medical School.